Author: Chen Li-Yan Huang Jian Zhang Xin-Ping Qiao Ping Zhang Wen Yang Ning-Min Liu Hong-Jing Geng Yong-Yao Qiu Jian-Ming Wang Sheng-Qi
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.6, Iss.7, 2005-10, pp. : 721-730
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Lamivudine: Development of resistance leading to HBV-related membranous nephropathy: case report
Reactions Weekly, Vol. 1, Iss. 1434, 2013-01 ,pp. :
Lamivudine may prevent HBV reactivation
Inpharma, Vol. 1, Iss. 1397, 2003-01 ,pp. :
Lamivudine can prevent post-transplant HBV infection
Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. :
Lamivudine a winner for preventing vertical transmission of HBV
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 644, 2012-01 ,pp. :